Address
Muenchensteinerstrasse 38
Basel, BW 4002
Switzerland
Phone
41 61 316 81 11
Website
Sector
Healthcare
Industry
Biotechnology
Employees
16866
First IPO Date
March 07, 2006
| Name | Title | Pay | Year Born |
| Wolfgang Wienand | Chief Executive Officer | 0 | 1972 |
| David Carter | Head of Communications | 0 | N/A |
| Gordon Bates | President of Small Molecules Division | 0 | 1965 |
| Jean-Christophe Hyvert | President of Biologics Division | 0 | 1972 |
| Christian Seufert | President of Capsules & Health Ingredients Division | 0 | 1975 |
| Matthias Hofmann | Head of Corporate Environment, Health, Safety & Global Sustainability | 0 | N/A |
| Andreas Bohrer | Chief Legal & Corporate Affairs Officer | 0 | N/A |
| Daniel Buchta | Head of Investor Relations | 0 | N/A |
| Jason Berndt | Executive Vice President & Head of Group Operations | 0 | N/A |
| Philippe Deecke | Chief Financial Officer | 0 | N/A |
| Jennifer Clancy | Senior Director of Global Marketing | 0 | N/A |
| Kim Harrelson | Head of Ethics & Compliance, ERM and Corporate Responsibility | 0 | N/A |
| Nicoleta Baumgartner | Chief Human Resources Officer | 0 | 1971 |
| Victoria Morgan | Head of External Communications | 0 | N/A |
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.